Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 3, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Docking study of HIV-1 reverse transcriptase with phytochemicals.

Abhik Seal, Riju Aykkal, Rosana O Babu

    Bioinformation
    |March 23, 2011
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Netpredictor: R and Shiny package to perform drug-target network analysis and prediction of missing links.

    BMC bioinformatics·2018
    Same author

    Predicting drug target interactions using meta-path-based semantic network analysis.

    BMC bioinformatics·2016
    Same author

    Optimizing drug-target interaction prediction based on random walk on heterogeneous networks.

    Journal of cheminformatics·2015
    Same author

    Tools, resources and databases for SNPs and indels in sequences: a review.

    International journal of bioinformatics research and applications·2014
    Same author

    An unusual form of groin hernia - a case report.

    Journal of the Indian Medical Association·2013
    Same author

    Eviscerated 'amyand' incisional hernia.

    The Journal of IMA·2013
    Same journal

    Assessment of lower incisor position and symphysis dimensions among different skeletal patterns in the Chhattisgarh population.

    Bioinformation·2026
    Same journal

    Low T3 syndrome and short-term outcomes in patients with acute decompensated heart failure: A retrospective observational study.

    Bioinformation·2026
    Same journal

    Cardiovascular risk prevention awareness and practices in type 2 diabetes: Linking HbA1c and lipid levels.

    Bioinformation·2026
    Same journal

    Assessment of periodontal condition using basic periodontal examination scores: A retrospective clinical study.

    Bioinformation·2026
    Same journal

    Comparative evaluation of osseointegration among different surface modification techniques in dental implants.

    Bioinformation·2026
    Same journal

    Micro-osteoperforations' impact on orthodontic tooth movement rate: Split mouth research.

    Bioinformation·2026
    See all related articles

    Natural compounds show promise for human immunodeficiency virus (HIV) drug discovery. Docking studies revealed several phytochemicals with effective binding, favorable drug likeness, and no adverse effects, suggesting potential for new HIV-1 therapies.

    Area of Science:

    • Medicinal Chemistry
    • Pharmacology
    • Drug Discovery

    Background:

    • Natural products are a vital resource for identifying novel therapeutic agents.
    • The human immunodeficiency virus (HIV) reverse transcriptase is a key target for antiviral drug development.

    Purpose of the Study:

    • To investigate the potential of various natural phytochemicals as inhibitors of HIV-1 reverse transcriptase.
    • To evaluate the binding efficacy, drug likeness, and safety profiles of selected natural compounds.

    Main Methods:

    • Molecular docking simulations were performed using different phytochemicals against the active sites of HIV-1 reverse transcriptase (PDB ID: 1REV).
    • Binding energy, ligand efficiency, carcinogenicity, mutagenicity, and drug likeness scores were assessed for each compound.

    More Related Videos

    Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
    05:46

    Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

    Published on: April 9, 2014

    Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
    06:03

    Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

    Published on: July 15, 2019

    Related Experiment Videos

    Last Updated: Jun 3, 2026

    Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
    10:29

    Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

    Published on: May 9, 2025

    Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
    05:46

    Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

    Published on: April 9, 2014

    Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
    06:03

    Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

    Published on: July 15, 2019

    Main Results:

    • Several natural compounds, including Curcumin, Geranin, Gallotannin, Tiliroside, Kaempferol-3-o-glucoside, and Trachelogenin, demonstrated significant binding affinity and favorable ligand efficiency.
    • These compounds exhibited no predicted adverse effects regarding carcinogenicity and mutagenicity, alongside favorable drug likeness profiles.

    Conclusions:

    • The studied natural products possess promising characteristics for the development of new anti-HIV-1 drugs.
    • Phytochemicals like Curcumin and Geranin are strong candidates for further investigation in HIV-1 drug discovery pipelines.